Cargando…

Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas

Survival from pancreatic cancer remains extremely poor, in part because this malignancy is not diagnosed in the early stages, and precancerous pancreatic intraepithelial neoplasia (PanIN) lesions are not seen on routine radiographic imaging. Since the cholecystokinin-B receptor (CCK-BR) becomes over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Jill P., Cao, Hong, Edmondson, Elijah F., Dasa, Siva Sai Krishna, Stern, Stephan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698999/ https://www.ncbi.nlm.nih.gov/pubmed/34944412 http://dx.doi.org/10.3390/biom11121766

Ejemplares similares

Precancerous Lesions and Carcinoma of the Pancreas
por: Hackert, Thilo, et al.
Publicado: (2015)

Precancerous Lesions and Carcinoma of the Pancreas
por: Büchler, Markus W., et al.
Publicado: (2015)

Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer
por: Burks, Julian, et al.
Publicado: (2018)

25380 Cholecystokinin-B Receptor -Mediates Growth of Hepatocellular Carcinoma
por: Gay, Martha Dee, et al.
Publicado: (2021)

Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression
por: Smith, Jill P., et al.
Publicado: (2023)

Stimulus-secretion coupling in the developing exocrine pancreas: secretory responsiveness to cholecystokinin
Publicado: (1986)

The Excitatory Effect of Cholecystokinin on Colonic Motor Function via Cholecystokinin(1) Receptor
por: Jun, Jae Yeoul
Publicado: (2011)

Cholecystokinin Activation of Cholecystokinin 1 Receptors: a Purkinje Cell Neuroprotective Pathway
por: Orr, Harry T.
Publicado: (2022)

Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non‐alcoholic Steatohepatitis
por: Rabiee, Atoosa, et al.
Publicado: (2022)

Techniques for Precancerous Lesion Diagnosis
por: Mendes, Sarah Freygang, et al.
Publicado: (2011)

Precancerous Lesions in Colorectal Cancer
por: Sandouk, Fayez, et al.
Publicado: (2013)

Dual pathways of internalization of the cholecystokinin receptor
Publicado: (1995)

A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma
por: Tucker, Robin D., et al.
Publicado: (2019)

Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence
por: Wen, Di, et al.
Publicado: (2012)

2297: Dietary fat stimulates growth of pancreatic cancer growth through the cholecystokinin receptor
por: Nadella, Sandeep, et al.
Publicado: (2018)

4119 Cholecystokinin (CCK) Receptor Antagonist Reverses Nonalcoholic Steatohepatitis (NASH) by Reducing Hepatic Macrophages and Inflammatory Cytokines
por: Gay, Martha, et al.
Publicado: (2020)

Serum cholecystokinin levels can be a predictive factor for difficult cholecystectomy: Decreased cholecystokinin receptor levels
por: Utku Yılmaz, Tonguç, et al.
Publicado: (2022)

Sensitivity of cholecystokinin receptors to membrane cholesterol content
por: Desai, Aditya J., et al.
Publicado: (2012)

Permanent Photodynamic Activation of the Cholecystokinin 2 Receptor
por: Tang, Wen Zhu, et al.
Publicado: (2020)

Gastric precancerous lesions:occurrence, development factors, and treatment
por: Cao, Yue, et al.
Publicado: (2023)

Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma
por: Shivapurkar, Narayan, et al.
Publicado: (2023)

Increased detection of precancerous cervical lesions with adjunctive dynamic spectral imaging
por: DeNardis, Sara A, et al.
Publicado: (2017)

Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment
por: Malchiodi, Zoe X., et al.
Publicado: (2021)

Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic
por: Jolly, Gurbani, et al.
Publicado: (2023)

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma
por: Clawson, Gary A., et al.
Publicado: (2017)

Cholecystokinin and the hormone concept
por: Rehfeld, Jens F
Publicado: (2021)

Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells
por: Mjønes, Patricia, et al.
Publicado: (2017)

Are histological alterations observed in the gallbladder precancerous lesions?
por: Meirelles-Costa, Adriana Lúcia Agnelli, et al.
Publicado: (2010)

Tuberculosis of the Oral Cavity Misdiagnosed as Precancerous Lesion
por: Vučičević Boras, Vanja, et al.
Publicado: (2017)

An “expressionistic” look at serrated precancerous colorectal lesions
por: Marra, Giancarlo
Publicado: (2021)

Early Localization of Bronchogenic Cancerous/Precancerous Lesions With Lung Imaging Fluorescence Endoscope
por: Ikeda, N., et al.
Publicado: (1997)

An Improved Image Classification Method for Cervical Precancerous Lesions Based on ShuffleNet
por: Fang, Shan, et al.
Publicado: (2022)

Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide
por: Yang, Yin, et al.
Publicado: (2018)

Ki-67 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions
por: Shi, Qin, et al.
Publicado: (2019)

Structural insights into human brain–gut peptide cholecystokinin receptors
por: Ding, Yu, et al.
Publicado: (2022)

Precancerous Lesions of the Gastrointestinal Tract: A Histological Classification
por: Rowlatt, C.
Publicado: (1986)

Immunologic treatments for precancerous lesions and uterine cervical cancer
por: Vici, Patrizia, et al.
Publicado: (2014)

Proteasome activity is required for the initiation of precancerous pancreatic lesions
por: Furuyama, Takaki, et al.
Publicado: (2016)

The Immune Landscapes of Polypoid and Nonpolypoid Precancerous Colorectal Lesions
por: Maglietta, Antonella, et al.
Publicado: (2016)

Molecular fingerprint of precancerous lesions in breast atypical hyperplasia
por: Zheng, Chao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2qvdlf2luhhsd9t879cia77ofg